Literature DB >> 24480312

Joint infectious causation of human cancers.

Paul W Ewald1, Holly A Swain Ewald2.   

Abstract

Joint infectious causation of cancer has been accepted in a few well-studied instances, including Burkitt's lymphoma and liver cancer. In general, evidence for the involvement of parasitic agents in oncogenesis has expanded, and recent advances in the application of molecular techniques have revealed specific mechanisms by which host cells are transformed. Many parasites evolve to circumvent immune-mediated detection and destruction and to control critical aspects of host cell reproduction and survival: cell proliferation, apoptosis, adhesion, and immortalization. The host has evolved tight regulation of these cellular processes-the control of each represents a barrier to cancer. These barriers need to be compromised for oncogenesis to occur. The abrogation of a barrier is therefore referred to as an essential cause of cancer. Alternatively, some aspects of cellular regulation restrain but do not block oncogenesis. Relaxation of a restraint is therefore referred to as an exacerbating cause of cancer. In this chapter, we explore past and current evidence for joint infectious causation of cancer in the context of essential and exacerbating causes. We stress that discovery of joint infectious causation may provide great improvements in controlling cancer, particularly through the identification of many additional nonhuman targets for synergistic interventions for prevention and treatment.
© 2014 Elsevier Ltd All rights reserved.

Entities:  

Keywords:  Barriers; Cancer; Coinfection; Evolution; Infection; Oncogenesis; Prevention; Vaccination

Mesh:

Year:  2014        PMID: 24480312     DOI: 10.1016/B978-0-12-800099-1.00001-6

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  7 in total

Review 1.  Infection and cancer in multicellular organisms.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

Review 2.  Genetic diversity, inbreeding and cancer.

Authors:  Beata Ujvari; Marcel Klaassen; Nynke Raven; Tracey Russell; Marion Vittecoq; Rodrigo Hamede; Frédéric Thomas; Thomas Madsen
Journal:  Proc Biol Sci       Date:  2018-03-28       Impact factor: 5.349

3.  The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

4.  Short- and long-term evolution in our arms race with cancer: Why the war on cancer is winnable.

Authors:  Jay A Rosenheim
Journal:  Evol Appl       Date:  2018-03-08       Impact factor: 5.183

5.  Parasite-microbe-host interactions and cancer risk.

Authors:  Nolwenn M Dheilly; Paul W Ewald; Paul J Brindley; Raina N Fichorova; Frédéric Thomas
Journal:  PLoS Pathog       Date:  2019-08-15       Impact factor: 6.823

6.  Can postfertile life stages evolve as an anticancer mechanism?

Authors:  Frédéric Thomas; Mathieu Giraudeau; François Renaud; Beata Ujvari; Benjamin Roche; Pascal Pujol; Michel Raymond; Jean-François Lemaitre; Alexandra Alvergne
Journal:  PLoS Biol       Date:  2019-12-05       Impact factor: 8.029

7.  Identifying key questions in the ecology and evolution of cancer.

Authors:  Antoine M Dujon; Athena Aktipis; Catherine Alix-Panabières; Sarah R Amend; Amy M Boddy; Joel S Brown; Jean-Pascal Capp; James DeGregori; Paul Ewald; Robert Gatenby; Marco Gerlinger; Mathieu Giraudeau; Rodrigo K Hamede; Elsa Hansen; Irina Kareva; Carlo C Maley; Andriy Marusyk; Nicholas McGranahan; Michael J Metzger; Aurora M Nedelcu; Robert Noble; Leonard Nunney; Kenneth J Pienta; Kornelia Polyak; Pascal Pujol; Andrew F Read; Benjamin Roche; Susanne Sebens; Eric Solary; Kateřina Staňková; Holly Swain Ewald; Frédéric Thomas; Beata Ujvari
Journal:  Evol Appl       Date:  2021-02-08       Impact factor: 5.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.